arrow
R

Rosaria Maddalena Ruggeri

University of Messina
H指数:38
被引数:4,099

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OC7.4 - ECE_1921 - Sex-specific determinants of treatment response and progression in neuroendocrine tumours: a multicentre gender-based analysis of SSAs and PRRT

OC7.4 - ECE_1921 - 神经内分泌肿瘤治疗反应和进展的性别特异性决定因素:SSAs和PRRT的多中心基于性别的分析

2026-08-100
OAAI
P96 - ECE_2118 - Clinical, biochemical, and histopathological features of CDC73 mutation carriers in pediatric and young-adult (≤21 years) patients with sporadic primary hyperparathyroidism

P96 - ECE_2118 - 散发性原发性甲状旁腺功能亢进症儿童及青年成人(≤21岁)患者中CDC73突变携带者的临床、生物化学及组织病理学特征

2026-08-100
OAAI
P97 - ECE_2376 - Real-life data about pregnancy and delivery in Italian women with X-linked hypophosphatemia: a survey-based multicenter study (the PPL-XLH study)

P97 - ECE_2376 - 关于意大利X连锁低磷酸盐血症女性妊娠和分娩的真实世界数据:一项基于调查的多中心研究(PPL-XLH研究)

2026-08-100
OAAI
The clinical challenge of MEN1 phenocopies: insights from a multicentric national retrospective study

MEN1表型模拟的临床挑战:来自一项多中心国家回顾性研究的见解

2025-11-120
OAAI
Correction: Experts’ consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan

更正:专家们对X-linked hypophosphatemia患者全生命周期管理及治疗的共识

2025-10-080
OA
Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database

慢性低甲状旁腺素血症患者的骨骼状况:来自意大利HypoparaNET数据库的结果

2025-07-230
OAAI
Experts’ consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan

专家关于X-linked hypophosphatemia患者全生命周期管理与治疗的共识

2025-07-010
OA
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions

胰高血糖素样肽-1受体激动剂和SGLT-2抑制剂在神经内分泌肿瘤合并糖尿病患者中的应用:最新进展与未来方向

2025-04-020
OA